BioRestorative Therapies BRTX
NASDAQ BRTX
$1.57 +0.02 (+1.29%)
As of: Nov 11, 2026 · 3:59 PM EST

BioRestorative Therapies (BRTX) Operating Margin (2012 - 2026)

Updated

BioRestorative Therapies' Operating Margin was -14612.57% in Q1 2026, up 4617.56 percentage points from -19230.14% a year earlier and up 4904.26 percentage points from the prior quarter.

Analysis

BioRestorative Therapies (BRTX) Operating Margin (2012 - 2026) Analysis & Trends

On a trailing twelve-month basis, BioRestorative Therapies' Operating Margin was -3975.00% through Mar 31, 2026, down 841.12 percentage points year-over-year; for FY2025, it was -4350.05%, down 1468.46 percentage points from FY2024.

  • Operating Margin shows a five-year change of -775.93 percentage points (FY2020 to FY2025).
  • In earlier years, Operating Margin was -2881.59% in FY2024 (+7557.89 pp), -10439.49% in FY2023 (+5398.60 pp), -15838.08% in FY2022 (+41352.94 pp) and -57191.03% in FY2021 (-53616.90 pp).
  • Quarterly Operating Margin has moved between -126537.95% (Q4 2022) and -979.02% (Q3 2024) over five years.
  • Compared with a year earlier, Operating Margin was higher in five of the last eight quarters, with an average year-over-year change of -2909.90 percentage points.
  • The best year-over-year quarter for Operating Margin over five years was Q4 2023 (a gain of 109850.47 percentage points); the worst was Q4 2021 (a drop of 75159.08 percentage points).
  • Per Business Quant data, BRTX's Operating Margin in the three quarters before Q1 2026 was -19516.84% (Q4 2025), -31432.30% (Q3 2025) and -1089.77% (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 BioRestorative Therapies 1.36 Mn -17.06 Mn 15,785.00 -14,612.57%
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -14,612.57%
Dec 31, 2025 -19,516.84%
Sep 30, 2025 -31,432.30%
Jun 30, 2025 -1,089.77%
Mar 31, 2025 -19,230.14%
Dec 31, 2024 -6,212.80%
Sep 30, 2024 -979.02%
Jun 30, 2024 -2,770.83%
Mar 31, 2024 -11,740.72%
Dec 31, 2023 -16,687.47%
Sep 30, 2023 -10,112.19%
Jun 30, 2023 -4,831.86%
Mar 31, 2023 -18,463.57%
Dec 31, 2022 -126,537.95%
Sep 30, 2022 -15,895.52%
Jun 30, 2022 -6,510.03%
Mar 31, 2022 -31,586.21%
Dec 31, 2021 -80,185.34%
Sep 30, 2021 -46,108.59%
Jun 30, 2021 -23,701.75%
API Access

BioRestorative Therapies Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=BRTX&period=max&api_key=YOUR_API_KEY